CMV antiviral may reduce inflammation and improve immune function in people with HIV

Aidsmap | March 21, 2025

First-in-Human Study of Long-Acting Injectable HIV Nanoparticle Combination Therapy

Contagion Live | March 19, 2025

Drug Regimen For HIV Shows Non-Inferiority to Antiretroviral Therapies 

Drug Topics | March 14, 2025

Merck releases positive phase 3 data on daily oral HIV drug

MSN | March 13, 2025

What's happening with the anti-HIV program PEPFAR? It depends whom you ask

NPR | February 13, 2025

US spells out life-saving HIV treatment that can continue during aid pause

Reuters | February 1, 2025

What to Do if You Can’t Get Your HIV Medication Costs Covered

The Body | January 29, 2025

Combination of Dolutegravir, Lamivudine Effective in People Living With HIV 

American Journal of Managed Care | January 22, 2025

NIAID Study Describes Successful Treatment Regimen for Person with Multidrug-Resistant HIV

NIH | January 16, 2025

DoxyPEP Tied to Decreases in Sexually Transmitted Infections

Health Day | January 7, 2025

WHO to Develop Lenacapavir and HIV Testing Guidelines

Managed Healthcare | January 7, 2025

Twice-Yearly Lenacapavir Could Support HIV Prevention in Vulnerable Populations

JAMA | January 3, 2025